51 related articles for article (PubMed ID: 16939734)
21. Kawasaki disease.
Harnden A; Tulloh R; Burgner D
BMJ; 2014 Sep; 349():g5336. PubMed ID: 25230954
[No Abstract] [Full Text] [Related]
22. Role of glucocorticoids in Kawasaki disease.
Miura M
Int J Rheum Dis; 2018 Jan; 21(1):70-75. PubMed ID: 29105310
[TBL] [Abstract][Full Text] [Related]
23. Advances in the treatment of Kawasaki disease.
Dominguez SR; Anderson MS
Curr Opin Pediatr; 2013 Feb; 25(1):103-9. PubMed ID: 23283289
[TBL] [Abstract][Full Text] [Related]
24. Hemophagocytic syndrome after Kawasaki disease.
Palazzi DL; McClain KL; Kaplan SL
Pediatr Infect Dis J; 2003 Jul; 22(7):663-6. PubMed ID: 12886898
[TBL] [Abstract][Full Text] [Related]
25. Recent developments and controversies in Kawasaki disease.
Guzman-Cottrill JA; Shulman ST
Minerva Pediatr; 2004 Feb; 56(1):51-61. PubMed ID: 15249914
[TBL] [Abstract][Full Text] [Related]
26. Acetylsalicylic acid for children with Kawasaki disease.
Sakulchit T; Benseler SM; Goldman RD
Can Fam Physician; 2017 Aug; 63(8):607-609. PubMed ID: 28807954
[No Abstract] [Full Text] [Related]
27. Kawasaki Disease.
Son MBF; Newburger JW
Pediatr Rev; 2018 Feb; 39(2):78-90. PubMed ID: 29437127
[No Abstract] [Full Text] [Related]
28. Kawasaki disease: diagnosis, management, and long-term implications.
Satou GM; Giamelli J; Gewitz MH
Cardiol Rev; 2007; 15(4):163-9. PubMed ID: 17575479
[TBL] [Abstract][Full Text] [Related]
29. Role of intravenous immunoglobulin in the treatment of Kawasaki disease.
Lo MS; Newburger JW
Int J Rheum Dis; 2018 Jan; 21(1):64-69. PubMed ID: 29205910
[TBL] [Abstract][Full Text] [Related]
30. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
Hung JJ; Chiu CH
Ann Trop Paediatr; 2004 Mar; 24(1):89-93. PubMed ID: 15005973
[TBL] [Abstract][Full Text] [Related]
31. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
Zhang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
[No Abstract] [Full Text] [Related]
32. Refractory Kawasaki disease.
Freeman AF; Shulman ST
Pediatr Infect Dis J; 2004 May; 23(5):463-4. PubMed ID: 15131473
[No Abstract] [Full Text] [Related]
33. Kawasaki disease: an overview.
Pinna GS; Kafetzis DA; Tselkas OI; Skevaki CL
Curr Opin Infect Dis; 2008 Jun; 21(3):263-70. PubMed ID: 18448971
[TBL] [Abstract][Full Text] [Related]
34. The role of corticosteroids in the treatment of Kawasaki disease.
Chang LS; Kuo HC
Expert Rev Anti Infect Ther; 2020 Feb; 18(2):155-164. PubMed ID: 31914832
[No Abstract] [Full Text] [Related]
35. What dose of aspirin should be used in the initial treatment of Kawasaki disease?
Ho LGY; Curtis N
Arch Dis Child; 2017 Dec; 102(12):1180-1182. PubMed ID: 29066520
[No Abstract] [Full Text] [Related]
36. Kawasaki shock syndrome in an Arab female: case report of a rare manifestation and review of literature.
Nugud AA; Nugud A; Wafadari D; Abuhammour W
BMC Pediatr; 2019 Aug; 19(1):295. PubMed ID: 31443702
[TBL] [Abstract][Full Text] [Related]
37. [Kawasaki disease (Kawasaki syndrome)].
Ohno T; Furuno K; Ikeda K; Hara T
Nihon Rinsho; 2005 May; 63 Suppl 5():391-9. PubMed ID: 15954382
[No Abstract] [Full Text] [Related]
38. [Prednisolone therapy for Kawasaki disease].
Kobayashi T; Kobayashi T; Arakawa H
Nihon Rinsho; 2014 Sep; 72(9):1623-8. PubMed ID: 25518413
[TBL] [Abstract][Full Text] [Related]
39. [Churg-Strauss syndrome--recent developments in diagnosis and treatment].
Hellmich B; Metzler C; Gross WL
Dtsch Med Wochenschr; 2006 Oct; 131(41):2270-4. PubMed ID: 17036268
[No Abstract] [Full Text] [Related]
40. [Present status of high-dose intravenous immunoglobulin therapy and the future prospects ].
Kawasugi K
Nihon Rinsho Meneki Gakkai Kaishi; 2003 Jun; 26(3):87-95. PubMed ID: 12868126
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
